Pfizer
Riddhi Naik Desai has extensive experience in the biopharmaceutical industry, currently serving as Sr. Manager PGS Co-dev Team Lead for Vaccines (non-mRNA) at Pfizer since August 2009. Previous roles at Pfizer include Sr. Manager for PGS Co-dev Lead SMCD, Operational Excellence/Operations Management Lead, Manager of Validation/Technical Services, Validation Engineer, and Scientist. Riddhi’s prior experience includes working as a Validation Specialist at A & J Consulting Engineering Services/Wyeth Biotech from July 2008 to July 2009 and as a Medical Technologist at Quest Diagnostics from May 2006 to June 2008. Educational qualifications include a Graduate Certification in Pharmaceutical Management and a Master of Science in Pharmaceutical Engineering from the New Jersey Institute of Technology, as well as a Bachelor's degree in Genetics with an emphasis on Microbiology from Rutgers University.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.